Sekisui Specialty Chemicals Has Announced a Global Price Increase
On April 4, Sekisui Specialty Chemicals announced that it will further increase the prices of its Selvol® polyvinyl alcohol, Selvol Ultiloc®, Selvol Ultalux®, and Selvol Premiol® product lines, signaling growing cost pressures in the global chemicals market.
The price increases by region are as follows:
- North America: USD 350 per metric ton
- Latin America: USD 350 per metric ton
- Asia: USD 650 per metric ton
- Europe, Middle East, and Africa: EUR 550 per metric ton
This price adjustment will take effect on April 15, 2026, or as permitted by contracts and agreements.
The company’s flagship product line, Selvol, consists of a range of high-performance polyvinyl alcohol polymers and copolymers used in paper, adhesives, packaging, construction, personal care, and many other specialty formulations.
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients
-
Afidopyropen: The Silent Assassin of Sap-Sucking Pests—Promise, Pitfalls, and the Path to Sustainable Deployment
-
Agrochemical Markets at a Crossroads: Winter Stockpiling Begins Amid Cost Pressures and Fragmented Demand
-
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Production
-
China Unveils Battery Breakthrough with 600Wh/kg Cell Flight Endurance Boosted 2.8 Times
-
CP Chem Doubles PAO Capacity in Belgium to 120000 Tons Now Europe’s Largest Low-Viscosity Base Oil Facility
-
Huayou Cobalt Reports 62 Percent Net Profit Surge in H1 2025 Lithium and Nickel Volumes Hit New Highs
-
Wanhua Chemical’s 2025 Revenue Exceeds RMB 200 Billion While Net Profit Remains Under Pressure
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
Recommend Reading
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Wall Street Predicts New Obesity Pills Will Be Priced Near $1000 Like Wegovy and Zepbound Supply and Competition Pressures Mount
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
This Week's Aniline Market Consolidation (8.18-8.22) in China
-
This Week's MDI Market Narrowly Declines (8.18-8.22) in China
-
This week, China's titanium dioxide market has shown a steady and positive trend (8.18-8.22)
-
This Week's Isopropanol Market Prices Decrease (8.18-8.22) in China
-
Stable Shipping, Stable Activated Carbon Prices in China